Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario

G. N. Srivastava, S. Anupurva (Varanasi, India)

Source: Annual Congress 2006 - Epidemiology and clinical aspects of tuberculosis
Session: Epidemiology and clinical aspects of tuberculosis
Session type: Poster Discussion
Number: 4941
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. N. Srivastava, S. Anupurva (Varanasi, India). Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario. Eur Respir J 2006; 28: Suppl. 50, 4941

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does the radiological manifestation of drug resistant pulmonary tuberculosis (PTB) in HIV non-infected/infected patients differ – an Indian picture
Source: Eur Respir J 2007; 30: Suppl. 51, 440s
Year: 2007

Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Antituberculosis drug-induced hepatotoxicity: influence on the management and outcome of active tuberculosis (TB)
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

Differences between age related clinical presentation of pulmonary tuberculosis (TB)
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011


The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Treatment outcome of MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007



On investigation of the reproductive function status among women with pulmonary tuberculosis (TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 416s
Year: 2005

Do results of T-SPOT.TB assays change during and after treatment of active tuberculosis?
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011

Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


A study of prevalence of depression in patients with multi drug resistant tuberculosis
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control
Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017
Year: 2017




Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?
Source: Eur Respir J 2005; 25: 751-757
Year: 2005



Skin test reactivity in non HIV pediatric patients exposed to TB active lung disease. Predictor of active disease
Source: Eur Respir J 2005; 26: Suppl. 49, 413s
Year: 2005